Ameritas Investment Partners’s Terns Pharmaceuticals TERN Stock Holding History

Ameritas Investment Partners’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$413K	Buy	7,842 +881	+13%	+$36.2K	0.01%	908
2025 Q4	$281K	Buy	6,961 +1,321	+23%	+$30.5K	0.01%	1055
2025 Q3	$42.4K	Hold	5,640	–	–	﹤0.01%	2261
2025 Q2	$21K	Hold	5,640	–	–	﹤0.01%	2631
2025 Q1	$15.6K	Hold	5,640	–	–	﹤0.01%	2658
2024 Q4	$31.2K	Hold	5,640	–	–	﹤0.01%	2438
2024 Q3	$47K	Hold	5,640	–	–	﹤0.01%	2226
2024 Q2	$38.4K	Buy	5,640 +2,101	+59%	+$12.7K	﹤0.01%	2284
2024 Q1	$23.2K	Hold	3,539	–	–	﹤0.01%	2502
2023 Q4	$23K	Hold	3,539	–	–	﹤0.01%	2521
2023 Q3	$17.8K	Hold	3,539	–	–	﹤0.01%	2598
2023 Q2	$31K	Buy	+3,539	New	+$41.2K	﹤0.01%	2316
2022 Q2	–	Sell	-708	Closed	-$2K	–	3229
2022 Q1	$2K	Hold	708	–	–	﹤0.01%	3052
2021 Q4	$5K	Hold	708	–	–	﹤0.01%	3046
2021 Q3	$7K	Hold	708	–	–	﹤0.01%	3007
2021 Q2	$9K	Hold	708	–	–	﹤0.01%	2947
2021 Q1	$16K	Buy	+708	New	+$15.5K	﹤0.01%	2660

Other funds holding TERN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Ameritas Investment Partners's TERN Position: Q1 2026 in Review

Ameritas Investment Partners increased its Terns Pharmaceuticals (TERN) stake by 13% in Q1 2026, buying an estimated $36.2K and bringing the position to 7,842 shares worth $413K. The position accounts for 0.01% of the portfolio, ranked #908.

Ameritas Investment Partners first reported a position in TERN in Q1 2021 and has held it in 17 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

Ameritas Investment Partners held 7,842 shares of Terns Pharmaceuticals worth $413K as of Q1 2026.
Ameritas Investment Partners bought 881 Terns Pharmaceuticals shares in Q1 2026, an estimated $36.2K.
Terns Pharmaceuticals made up 0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #908 holding.
Ameritas Investment Partners first reported a position in Terns Pharmaceuticals in Q1 2021 and has held it in 17 quarters since.
317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.